|
STIM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.559520E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.533700E-02 |
| Normal-vs-Stage2 |
3.884400E-03 |
| Normal-vs-Stage3 |
9.93530000048537E-07 |
| Normal-vs-Stage4 |
1.798450E-01 |
| Stage1-vs-Stage2 |
4.182000E-01 |
| Stage1-vs-Stage3 |
3.284200E-02 |
| Stage1-vs-Stage4 |
9.882400E-01 |
| Stage2-vs-Stage3 |
1.174190E-01 |
| Stage2-vs-Stage4 |
5.185000E-01 |
| Stage3-vs-Stage4 |
1.956040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.284300E-03 |
| Normal-vs-AfricanAmerican |
2.806100E-02 |
| Normal-vs-Asian |
1.978030E-01 |
| Caucasian-vs-AfricanAmerican |
5.938800E-01 |
| Caucasian-vs-Asian |
5.326600E-01 |
| AfricanAmerican-vs-Asian |
9.196400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.46280000001831E-06 |
| Normal-vs-Female |
7.523000E-01 |
| Male-vs-Female |
1.041810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.980200E-02 |
| Normal-vs-Extreme_Weight |
2.057800E-01 |
| Normal-vs-Obese |
3.594100E-04 |
| Normal-vs-Extreme_Obese |
1.87549999997039E-06 |
| Normal_Weight-vs-Extreme_Weight |
9.133200E-01 |
| Normal_Weight-vs-Obese |
4.541600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.558400E-02 |
| Extreme_Weight-vs-Obese |
4.979000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.200410E-01 |
| Obese-vs-Extreme_Obese |
5.661700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.722500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.891190E-01 |
| Normal-vs-Age(61-80Yrs) |
1.799510E-04 |
| Normal-vs-Age(81-100Yrs) |
6.04639999999268E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.897600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.851600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.375800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.152030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.293890E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.852400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.50381999999283E-05 |
| Normal-VS-Type2 PRCC |
7.122200E-03 |
| Normal-VS-KIRP CIMP |
1.566960E-01 |
| Normal-VS-Unclassified PRCC |
5.524200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.170200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.316100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.463200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.630400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.141600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.657200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.47329999983437E-07 |
| Normal-vs-N1 |
1.519170E-03 |
| Normal-vs-N2 |
9.000800E-01 |
| N0-vs-N1 |
1.932370E-01 |
| N0-vs-N2 |
1.759750E-01 |
| N1-vs-N2 |
9.522500E-02 |
|
|
